Form 8-K - Current report:
SEC Accession No. 0001157523-21-000158
Filing Date
2021-02-10
Accepted
2021-02-10 07:00:27
Documents
13
Period of Report
2021-02-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K a52376888.htm   iXBRL 8-K 37991
2 EXHIBIT 99.1 a52376888ex99_1.htm EX-99.1 1236245
  Complete submission text file 0001157523-21-000158.txt   1478943

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA teva-20210210.xsd EX-101.SCH 4198
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20210210_lab.xml EX-101.LAB 23692
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20210210_pre.xml EX-101.PRE 16832
6 EXTRACTED XBRL INSTANCE DOCUMENT a52376888_htm.xml XML 4471
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 21609258
SIC: 2834 Pharmaceutical Preparations